H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares traded.
H. Lundbeck A/S Stock Performance
The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The stock’s 50 day moving average is $22.00 and its two-hundred day moving average is $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S (OTCMKTS:HLUYY) is a Danish pharmaceutical company headquartered in Copenhagen that specializes in the research, development and commercialization of medicines for disorders of the central nervous system. Founded in 1915 by Hans Lundbeck, the company has built a long-standing focus on neuroscience, concentrating on therapies for psychiatric and neurological conditions rather than broader therapeutic areas.
Lundbeck’s primary activities include discovery and clinical development of novel compounds, regulatory filings, manufacturing and global commercialization of prescription medicines aimed at brain health.
See Also
- Five stocks we like better than H. Lundbeck A/S
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
